Are you tired of constantly battling high cholesterol levels? If so, Lofibra may be the solution for you. This medication is known to reduce bad cholesterol and increase good cholesterol in patients suffering from hyperlipidemia. However, like any other drug, it comes with its own set of side effects that must not be overlooked. In this blog post, we will explore the benefits and side effects of Lofibra to help you make an informed decision about its use. So sit back and let’s dive into everything there is to know about Lofibra!
Lofibra is a prescription medication used to treat high cholesterol. It is also known as fenofibrate. Lofibra lowers cholesterol by reducing the production of LDL (bad) cholesterol in the liver and increasing the removal of LDL cholesterol from the blood. Lofibra also decreases the amount of triglycerides in the blood.
Lofibra belongs to a class of drugs called fibrates. Fenofibrate is the generic form of Lofibra.
Lofibra is available as a tablet and an oral suspension. The tablets are available in three strengths: 54 mg, 160 mg, and 267 mg. The oral suspension is available in one strength: 40 mg/mL.
The recommended starting dose for adults with high cholesterol is 54 mg or 160 mg once daily. The recommended starting dose for adults with high triglycerides is 160 mg once daily.
Lofibra can be taken with or without food.
Common side effects of Lofibra include headache, stomach pain, gas, bloating, diarrhea, and constipation.
Lofibra is a type of cholesterol-lowering medication. It is used to treat high cholesterol and triglyceride levels. There are two different types of Lofibra: Lofibra (fenofibrate) and Tricor (fenofibrate).
Lofibra is the brand name for fenofibrate. Fenofibrate lowers cholesterol and triglycerides by reducing the production of LDL (bad) cholesterol in the liver and increasing the breakdown of triglycerides. Fenofibrate also helps to prevent the absorption of cholesterol from the intestine.
Tricor is the brand name for fenofibrate. Fenofibrate lowers cholesterol and triglycerides by inhibiting the synthesis of VLDL (very low-density lipoprotein), which is a precursor to LDL (bad) cholesterol. Fenofibrate also reduces the absorption of dietary fat and decreases the production of triglycerides in the liver.
Both Lofibra and Tricor are effective at lowering cholesterol and triglyceride levels. However, they have different side effects. Lofibra may cause gastrointestinal side effects such as diarrhea, nausea, and gas. Tricor may cause muscle pain or weakness, skin rash, or headaches.
Lofibra (fenofibrate) is a prescription drug used to lower cholesterol and triglycerides in the blood. It belongs to a class of drugs called fibrates.
Fenofibrate is also available as a generic drug. Generic drugs usually cost less than the brand-name version. In some cases, they may not be available in all strengths or forms as the brand-name drug.
Pros:
The main pro of Lofibra is that it can help to lower cholesterol and triglyceride levels in the blood, which can reduce the risk of heart disease. Additionally, Lofibra is generally well-tolerated with few side effects.
Cons:
Additionally, like other fibrates, Lofibra may cause gastrointestinal side effects like bloating, gas, and diarrhea.
If you're looking for alternatives to Lofibra, there are a few options available. One alternative is Lipitor, which is used to treat high cholesterol. Another alternative is Zocor, which is also used to treat high cholesterol.
Lofibra is a prescription medication that is used to lower cholesterol levels. It works by reducing the amount of low-density lipoprotein (LDL) in your blood. LDL is the "bad" cholesterol that can build up on the walls of your arteries and lead to heart disease. Lofibra can also help increase the level of HDL ("good" cholesterol) in your blood.
Lofibra is generally well-tolerated, but side effects can include headache, diarrhea, and fatigue.
All in all, the benefits of Lofibra far outweigh the potential side effects. It is an important tool for those living with high cholesterol or triglyceride levels and it can help control these numbers with minimal effort.
1.
According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.
2.
Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness
3.
Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer
4.
According to a study, taking part in a clinical trial for cancer may not actually increase survival.
5.
A new blood test greatly increases the ability to detect cancer.
1.
Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis
2.
Unraveling the Mysteries of Hematocrit: How It Impacts Your Health
3.
The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers
4.
Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer
5.
Surprising Symptoms of Prostate Cancer: What You Need to Know
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part X
2.
Efficient Management of First line ALK-rearranged NSCLC - Part III
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation